Neurokinin-receptor antagonists (Formulary)

APREPITANT

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Capsules 80mg, 125mg (s)

Important: Formulation and dosage details

Formulation:

Powder for oral suspension 125mg (s)

FOSAPREPITANT

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 150mg (s)

Editorial Information

Document Id: F086